Theralase Technologies Inc. V.TLT

Heliyon Published 15 June 2024,

[Oden6570]

Nanomolar concentrations of the photodynamic compound TLD-1433 effectively inactivate numerous human pathogenic viruses - ScienceDirect

[Oden6570]

It would be nice to see some deep pocketed partner emerge to move this forward quickly.. Feds would be smart to pony up and sell vaccine world wide using profits to subsidize Canadian Health Cate.

[wildbird1]

Oden6570 great find... The big question? Is the government of Canada involved? The answer is in the list of experts that worked on the project. Darwyn Kobasa... Special pathogens program, National Microbiology Laboratory, Public health Agency Of Canada. In this link... https://science.gc.ca/site/science/en/blogs/science-health/keeping-eye-bird-flu It is said '' Darwyn Kobasa and the

[CAinPlap]

I would think the academic partner would be Dr Coombs/U of M.  

[CancerSlayer]

Thanks Wildbird...I'm certainly smelling a grant...could possibly explain the confidence in raising $10 million? Per the June 4, 2024 release from Theralase: "The research was completed at the laboratory of Kevin Coombs, Ph.D., University of Manitoba in conjunction with National Microbiology Laboratory and Theralase® Technologies Inc."

[CancerSlayer]

Yep...Dr. Coombs & Dr. Kobasa are both on faculty at U of M (professor & adjunct professor, respectively) studying viral pathogenesis.  The academic partner would be Dr. Coombs (research was completed in his lab at the U of M) & the tech/other expertise provided by Theralase.   I smell a grant & much more...JMO.